Stable Slit3 repression induced the growth of HCC cells in vitro and in vivo, and induced chemoresistance to oxaliplatin, 5-FU or sorafenib, through the negative regulatory effect on β-catenin expression. This evidence concerns the gene SLIT3 and hepatocellular carcinoma.